Efficacy (95% confidence intervals) | ||||||
---|---|---|---|---|---|---|
Benguela | Zaire | Lunda Sul | ||||
ASAQa | ALa | ALa | DPb | DPb | ASAQa | |
Uncorrected | ||||||
Per-protocol Day 28 | 90.4 (81–96) | 89.4 (80–95) | 75.3 (65–83) | 95.6 (88–99) | 100 (94–100) | 100 (92–100) |
Per-protocol Day 42 | – | – | – | 81.9 (72–89) | 100 (94–100) | – |
Kaplan–Meier estimate Day 28 | 90.3 (84–97) | 89.6 (83–96) | 76.0 (68–85) | 95.5 (91–100) | 100 | 100 |
Kaplan–Meier estimate Day 42 | – | – | – | 82.5 (75–91) | 100 | – |
PCR-corrected | ||||||
Per-protocol Day 28 | 99.9 (95–100) | 96.1 (89–99) | 86.5 (77–92) | 98.8 (94–99) | 100 (96–100) | 100 (94–100) |
Per-protocol Day 42 | – | – | – | 98.5 (92–99) | 100 (96–100) | – |
Kaplan–Meier estimate Day 28 | 99.9 (95–100) | 96.3 (91–100) | 88.1 (81–95) | 98.8 (96–100) | 100 | 100 |
Kaplan–Meier estimate Day 42 | – | – | – | 98.8 (96–100) | 100 | – |